Stacy Amin joined Romaine Bostick and Katie Greifeld on Bloomberg Markets The Close on Bloomberg Television to discuss how a shutdown of the United States government would affect the U.S. Food and Drug Administration (FDA).
“FDA has been clear that work related to a pending submission can continue,” said Stacy. “But if you’re a company planning to file next week, you will not be able to do that.”
Watch now.